Desmoid Oncology Territory Manager — Launch

Immunome; United States; Remote; USD 210,000 - 235,000; Full time

Benefits offered by this job

Health insurance

401(k) with employer match

Life insurance, disability, AD&D

Paid time off & holidays

Parental leave

Job summary

Immunome is seeking a Senior Oncology Account Manager to drive territory-level sales in preparation for and following the potential launch of varegacestat in desmoid tumors. You will build strong relationships with healthcare providers, execute local brand strategy, and ensure patients and physicians have information and support to consider varegacestat as a treatment option, grounded in patient centricity.

As a core member of the U.S.

Qualifications

• Bachelor's degree is required.
• 7+ years of pharmaceutical or biotech oncology sales experience.
• Experience launching an oncology product is desirable.
• Strong communication and relationship-building skills are essential.
• Willingness to travel up to 60–80%.

Responsibilities

• Achieve or exceed territory sales goals aligned with brand strategy.
• Develop territory business plans, identify priority accounts, and plan calls.
• Deliver compliant, clear clinical and value-based selling messages.
• Build relationships with physicians, nurses, and staff in the territory.
• Collaborate with Market Development, Marketing, Market Access, and Medical Affairs.
• Ensure compliant promotional activities and educate providers as needed.

Skills

Oncology sales

Territory sales management

CRM proficiency

Relationship building

Communication skills

Travel availability

Education

Bachelor's degree

Tools

CRM software

Job description

Immunome is seeking a Senior Oncology Account Manager to drive territory-level sales in preparation for and following the potential launch of varegacestat in desmoid tumors. You will build strong relationships with healthcare providers, execute local brand strategy, and ensure patients and physicians have information and support to consider varegacestat as a treatment option, grounded in patient centricity.

As a core member of the U.S.